Literature DB >> 6742788

Chronicity of hyponatremia as a factor in experimental myelinolysis.

M D Norenberg, R E Papendick.   

Abstract

A recent analysis of hyponatremic patients disclosed that those who were chronically hyponatremic prior to rapid correction subsequently developed central pontine myelinolysis. To test the view that chronicity of hyponatremia is a factor in myelinolysis, we studied a group of rats that were hyponatremic for 1 day and compared it with another group of animals maintained in a hyponatremic state for 3 days prior to the administration of hypertonic saline solution. The 3-day hyponatremic rats developed more numerous and more severe demyelinative lesions than the 1-day rats. The findings support the view that duration of hyponatremia is a factor in myelinolysis and that the electrolyte disturbance of chronically hyponatremic patients should be corrected cautiously and relatively slowly.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6742788     DOI: 10.1002/ana.410150606

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  14 in total

Review 1.  [Central pontine myelosis. Morphology and forensic importance].

Authors:  H Bratzke; K Neumann
Journal:  Z Rechtsmed       Date:  1989

2.  Central pontine myelinolysis: historical and mechanistic considerations.

Authors:  Michael D Norenberg
Journal:  Metab Brain Dis       Date:  2010-02-25       Impact factor: 3.584

3.  Neurological complications associated with parenteral treatment: central pontine myelinolysis and Wernicke's encephalopathy.

Authors:  P D Thompson; R F Gledhill; N P Quinn; M N Rossor; P Stanley; E N Coomes
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-08

4.  [Central pontine myelinolysis following severe hyponatremia].

Authors:  J A Schmidt; A Krause; C O Feddersen; F V Kohl; G Mariss; A Lütcke; P von Wichert
Journal:  Klin Wochenschr       Date:  1990-02-01

5.  Changes in glial cell markers in recent and old demyelinated lesions in central pontine myelinolysis.

Authors:  A Gocht; J Löhler
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

6.  Management of hyponatremia in various clinical situations.

Authors:  Michael L Moritz; Juan C Ayus
Journal:  Curr Treat Options Neurol       Date:  2014-09       Impact factor: 3.598

Review 7.  Cell volume regulation: a review of cerebral adaptive mechanisms and implications for clinical treatment of osmolal disturbances: II.

Authors:  H Trachtman
Journal:  Pediatr Nephrol       Date:  1992-01       Impact factor: 3.714

8.  Central pontine myelinolysis in liver transplantation.

Authors:  A P Boon; M P Carey; D H Adams; J Buckels; P McMaster
Journal:  J Clin Pathol       Date:  1991-11       Impact factor: 3.411

9.  Mild central pontine myelinolysis: a frequently undetected syndrome.

Authors:  H W Pfister; K M Einhäupl; T Brandt
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1985

10.  Rapidity of Correction of Hyponatremia Due to Syndrome of Inappropriate Secretion of Antidiuretic Hormone Following Tolvaptan.

Authors:  Jesse H Morris; Nicole M Bohm; Branden D Nemecek; Rachel Crawford; Denise Kelley; Bhavna Bhasin; Paul J Nietert; Juan Carlos Q Velez
Journal:  Am J Kidney Dis       Date:  2018-02-23       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.